Do complex conditions require complex treatment?

American Journal of Respiratory and Critical Care Medicine

Volumn 167, Issue 1, 2003, Pages 6-

  Inman, Mark ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; EOTAXIN; INTERLEUKIN 13; PREDNISOLONE;

ASTHMA; CELL HYPERPLASIA; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; GOBLET CELL; NONHUMAN; PRIORITY JOURNAL;

ADRENAL CORTEX HORMONES; ANIMALS; ASTHMA; INTERLEUKIN-13; MICE;

EID: 0037216613     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2210003     Document Type: Editorial

References (11)

1. Kibe A, Inoue H, Fukuyama S, Machida K, Matsumoto K, Koto H, Ikegami T, Aizawa H, Hara N. Differential regulation by glucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways. Am J Respir Crit Care Med 2003;167:50-56.
2. Kroegel C, Julius P, Matthys H, Virchow JC Jr, Luttmann W. Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: Relationship to interleukin-4 and eosinophil counts. Eur Respir J 1996;9:899-904.
3. Humbert M, Durham SR, Kimmitt P, Powell N, Assoufi B, Pfister R, Menz G, Kay AB, Corrigan CJ. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol 1997;99:657-665.
4. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD. Interleukin-13: Central mediator of allergic asthma. Science 1998;282:2258-2261.
5. Blease K, Jakubzick C, Schuh JM, Joshi BH, Puri RK, Hogaboam CM. IL-13 fusion cytotoxin ameliorates chronic fungal-induced allergic airway disease in mice. J Immunol 2001;167:6583-6592.
6. Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, Shipley JM, Gotwals P, Noble P, Chen Q, et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med 2001;194:809-821.
7. Naseer T, Minshall EM, Leung D, Laberge S, Ernst P, Martin RJ, Hamid Q. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 1997;155:845-851.
8. Fushimi T, Okayama H, Shimura S, Saitoh H, Shirato K. Dexamethasone suppresses gene expression and production of IL-13 by human mast cell line and lung mast cells. J Allergy Clin Immunol 1998;102:134-142.
9. Braun CM, Huang SK, Bashian GG, Kagey-Sobotka A, Lichtenstein LM, Essayan DM. Corticosteroid modulation of human, antigen-specific Th1 and Th2 responses. J Allergy Clin Immunol 1997;100:400-407.
10. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma: Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-1411.
11. Pauwels RA, Pedersen S, Tan WC, Chen YZ, Ohlsen SV, Ullman A, Lam CJ, O'Byrne PM. Early intervention with budesonide in mild persistent asthma - The START study. Eur Respir J 2002;22:3005s.